Thyroid hormone therapy modulates hypothalamo-pituitaryadrenal
|
|
- Evan Roberts
- 5 years ago
- Views:
Transcription
1 Endocrine Journal 2011, 58 (2), No t e Thyroid hormone therapy modulates hypothalamo-pituitaryadrenal axis Fernando Lizcano 1) and Javier Salvador Rodríguez 2) 1) Center of Biomedical Research La Sabana University, Chia, Colombia 2) University Clinic of Navarra, Pamplona, Spain Abstract. To observe the influence of thyroid hormone therapy on hypothalamo-pituitary-adrenal (HPA) axis, a group of 14 athyreotic women due to thyroid cancer treatment were studied before and after thyroid suppression therapy with thyroxine (T4). Changes in plasma adrenocorticotropin (ACTH) and cortisol levels in response to human corticotropinreleasing hormone (hcrh; 100μg, i.v.) were estimated under hypothyroid conditions and after T4 suppression therapy with 2.5µg/kg/day for two months (n=14). A group of seven healthy women was evaluated as a control group. A greater increase in ACTH levels by hcrh was observed in patient group both before and after suppression therapy compared than that of control group. Plasma cortisol levels after hcrh stimulation were also greater in patient group both before and after suppression therapy than that of control group. In conclusion, both hypothyroidism and subclinical hyperthyroidism with suppressive doses of thyroid hormone induced a hypersensitivity of ACTH to hcrh. Considering the role of thyroid hormone on HPA axis, the mechanisms of ACTH hypersensitivity may be different between these two conditions. Key words: Adrenocorticotropin, hcrh, Cortisol, Thyroid hormone, Hypothalamo pituitary adrenal axis Thyroid hormones (thyroxine, T4; triiodothyronine, T3) have intricate effects in different organs [1, 2]. Subclinical hyperthyroidism, characterized by low thyroid stimulating hormone (TSH) and normal free thyroid hormone concentrations in serum, has been associated with an independent risk factor for Alzheimer s disease, cognitive dysfunction and cardiovascular diseases [3-5]. We have previously demonstrated that hyperthyroid patients have an adrenocorticotropin (ACTH) hypersensitivity to human corticotropin-releasing hormone (hcrh) [6]. On the other hand, another study showed a decreased response of cortisol to ACTH administration, which may be due to diminished adrenocortical reserve [7]. These findings indicate that hyperthyroidism modulates hypothalamo-pituitary-adrenal (HPA) axis. Patients on thyroid suppression therapy due to differentiated thyroid cancer usually have subclinical hyperthyroidism, which may increase the risks of a mild irreg- Received Nov. 29, 2010; Accepted Nov. 30, 2010 as K10E-369 Released online in J-STAGE as advance publication Jan. 21, 2011 Correspondence to: Fernando Lizcano, Center of Biomedical Research. La Sabana University, km 7 Autopista Norte de Bogota, Chia, Colombia. fernando.lizcano@unisabana.edu.co. The Japan Endocrine Society ular heart rhythms and decrease in bone density [8]. However, a small number of studies have examined the consequences of thyroid suppression therapy on HPA axis [9]. In order to investigate the changes in HPA axis following thyroid hormone therapy, a group of hypothyroid patients was studied before and after administration of L-T4 (levothyroxine) suppressive doses (2.5µg/ kg/day) for two months. Methods Patients Fourteen hypothyroid women aged between 30 and 57 years (mean age 42.9±3.2 years) were studied. All patients had an ablative therapy for a thyroid cancer with total surgical thyroidectomy and I 131 therapy. During the study, a total body I 131 scan was negative for thyroid remnants, and plasma thyroglobulin levels were below detectable concentration. One month after the ablative therapy, patients reached to hypothyroid state, which was confirmed by measuring plasma TSH concentration, whose mean levels were 89.9±7.1 mu/l with a range of mu/l (normal range: mu/l). No patients had any additional diseases.
2 138 Lizcano et al. Table 1 Total and free thyroid hormone, thyroid-stimultaing hormone, arginine vaopressin and urinary free cortisol in normal women, hypothyroid patients before and after treatment with thyroid suppressive therapy during the following month with 2.5 μg/kg/day. TSH (mu/l) ( ) TT4 (nmol/l) (70-118) FT4 (pmol/l) (9-28) TT3 (nmol/l) ( ) FT3 (pmol/l) ( ) AVP (pmol/l) ( ) UFC (nmol/day) (55-276) Normal (n=7) 1.1 ± ± ± ± ± ± ± 19 Hypothyroid (n=14) 94 ± 7.4*** 16 ± 3.1*** 1.3 ± 0.01** 0.9 ± 0.08** 1 ± ± ± 24 Supressive therapy (n=14) 0.09 ± 0.03*** 139 ± 5.8** 27 ± 2.9* 1.8 ± ± 0.2* 4.8 ± 0.8* 308 ± 44** Values are mean±sem. *p<0.05, **p<0.01, ***p< Relation with normal. TSH, thyroid-stimulating hormone; TT4, FT4, total and free thyroxine, respectively; TT3, FT3 total and free tri-iodothyronine, respectively; AVP, arginine vasopressine; UFC, urinary free cortisol. A group of seven healthy, non-obese, nonsmoking women aged between 24 and 45 years (mean age 36.2 ± 8.2 years, not statistically significant from those for hypothyroid patients) were studied as a control group. Informed consent was obtained from all subjects and the ethics committee of the Navarre Clinic University approved the study. Study design To reduce individual variations in ACTH and cortisol levels that are usually observed in the morning, the CRH test was performed in the afternoon (10). All patients and control subjects underwent the hcrh test at 17:00 hours as follows; After three basal blood samples (3 ml/each sample) had been obtained at 15 min intervals, a bolus intravenous administration of 100 μg hcrh (Clinalfa, Weil am Rhei, Germany) was performed and blood samples were obtained at 30, 45, 60, 90 and 120 min after the injection. After the hcrh test, all patients underwent thyroid suppression therapy with L-T4 (2.5µg/kg/day) and the hcrh test was performed two months afterward. Hormone assays ACTH and cortisol levels were measured by immunoradiometric assay (IRMA) and radioimmunoassay (RIA), respectively, as reported previously (6). Total (T) T4, TT3, Free T4 and Free T3 levels were measured by radioimmunoassay (RIA) using commercially available kits (CIS Bio-International, Gif-sur-Ivette, France), as reported previously (6). TSH concentrations were measured by IRMA (CIS Bio-International). Intraand interassay coefficient of variation (CV) for the TSH assay were 3.5 and 4.7%, respectively. Arginine vasopressin was measured by RIA (Buhlmann Laboratories, Shönenbuch, Switzerland). The sensitivity of the AVP assay was 0.7 pmol/l and the intra- and interassay CV were 9 and 15%, respectively. All samples from a sin- gle patient were analyzed simultaneously. Data analysis Basal and stimulated levels of ACTH and cortisol obtained before and after treatment were compared. Maximum peaks, absolute increments and the area under the curve (AUC) were estimated in each case. Statistical analyses were performed using non-parametric Wilcoxon s sum paired rank test. Comparisons between groups were made using the unpaired nonparametric method of Mann-Whitney. Data are presented as the mean±sem. Results One month after the ablative therapy, all patients reached the hypothyroid state that was determined by TSH levels. The suppression therapy for two months produced elevation of FT4 and reduction of TSH in the range of subclinical hyperthyroidism (Table 1). Compared with normal subjects, patients under hypothyroid condition did not show significant differences in basal levels of ACTH or cortisol. However, the response of ACTH and cortisol to hcrh were significantly greater compared with those of control group, as assessed by maximum plasma concentrations for ACTH (14.92±1.9 vs. 7.7±0.6 pmol/l, p< 0.05) and cortisol (710±32 vs. 596±34 nmol/l, p< 0.05). This elevation was also evident in the AUC for ACTH (1248±230 vs. 618±59.4 pmol/l/150 min, p< 0.05), and cortisol (78400±5892 vs ±1830 nmol/l /150min, p<0.05) (Fig.1 A, B). When the patients with the suppression therapy (n=14) were evaluated at two months after the onset of thyroid hormone treatment, we observed an increase in ACTH basal (-30, 15, 0 min) levels compared with those of pre-treatment (5.8±0.67 vs. 2.8±0.63 pmol/l, p<0.05). The ACTH levels were also greater than
3 Thyroid hormone and HPA axis 139 A B Fig. 1 (A) Adrenocorticotropin (ACTH) and (B) cortisol responses to human corticotropin-releasing hormone (hcrh; 100 μg, i.v.) injection in hypothyroid patients (n = 14; ) and normal subjects (n = 7; ). (A) Basal levels of ACTH were not significantly different between two groups. However, after hcrh administration, greater ACTH levels were observed in hypothyroid patients at 30 and 45 min. (B) Basal cortisol levels were greater in normal subjects, but hcrh-stimulated cortisol levels were significantly greater in hypothyroid patients. Data are the mean±sem. *p < 0.05 compared with normal subjects. those of normal subjects (3.1±0.46, p<0.05). We also observed an ACTH hypersensitivity to hcrh reaching a maximum peak of secretion and AUC similar to the one observed during the hypothyroid condition (ACTH: 16.5±0.83 vs. 14.9±1.9 pmol/l, AUC: 1948±220 vs. 1248±230 pmol/l, at 150min). Cortisol basal levels were similar before and after thyroid hormone therapy. However, the maximum peak of secretion after hcrh was slightly reduced (628±29 vs. 710±32 nmol/l), although no significance was observed (Fig. 2B). Compared with normal subjects, cortisol levels after suppression therapy were greater at 30, 45 and 90 min, but not at 60 min (Fig. 1A and 2B). Discussion In the present study, we showed for the first time that both acute hypothyroidism by ablative therapy and subclinical hyperthyroidism induced by thyroid suppression therapy followed by the ablation have
4 140 Lizcano et al. A B Fig. 2 (A) ACTH and (B) cortisol responses to human hcrh (100 μg, i.v.) in hypothyroid patients (n = 14) before ( ) and after (Δ) treatment of suppressive doses (2.5µg/kg/day) of thyroid hormone. (A) Basal ACTH levels were greater with suppressive doses of thyroid hormone. However, hcrh-stimulated increases in ACTH levels were similar before and after two thyroid hormone treatment for 2 months. (B) Basal and ACTH-stimulated cortisol levels remains similar before and after thyroid hormone treatment. of thyroid cancer. These series of treatment (complete thyroid ablation with high dose of thyroid hormone) are sometimes performed to reduce the recurrence of cancer [11, 12]. However, such high dose of thyroid hormone may affect HPA axis, since we have previously reported that hyperthyroid patients show hyperactivity of HPA axis with augmented ACTH responses to exogenous hcrh, but with a practically normal response of cortisol [6]. In the present study, patients with supinduced a hypersensitivity of ACTH to hcrh. Basal ACTH secretions were also increased after thyroid hormone treatment. These results indicate that both hypo- and hyperthyroidism induces an alteration of the HPA axis. In the present study, we used a high dose of T4 (2.5µg/kg/day). Such high dose is often administered to patients after an ablative therapy with combination of surgery and radioactive iodine for treatment
5 Thyroid hormone and HPA axis 141 pressive dose of thyroid hormone also showed hypersensitivity of ACTH to exogenous hcrh, indicating that subclinical hyperthyroidism induced by thyroid hormone suppression therapy also activated HPA axis. A previous study has shown that hyperthyroidism induces hyperactivity of HPA axis mainly by inducing hypersensitivity of cortisol to ACTH [13]. In the present study, we have demonstrated that ACTH is also hypersensitive to hcrh under hyperthyroid condition. On the other hand, a previous study has shown that prolonged hyperthyroidism or severe hyperthyroidism induces a decrease in cortisol reserve in adrenal gland, which may result in reduced level of plasma cortisol [13]. This may be not the case in the present study, since patients hyperthyroidism is rather mild. Thus, cortisol reserve in adrenal gland is not decreased to respond normally to the elevated ACTH (Fig. 2B). In the present study, not only subclinical hyperthyroid patients, but also hypothyroid patients before the suppression therapy showed a greater response of ACTH secretion to hcrh. It may seem to be strange, but a previous animal study has also shown that hypothyroidism induced a greater response of ACTH secretion to CRH administration [14], which is consistent with present study. In this previous study, cortisol secretion to ACTH was decreased, resulting in hyposecretion of cortisol [14]. In the present study, hcrh administration induced approximately two-fold increase in ACTH secretion at peak level in hypothyroid patient compared with that of control (Fig. 1A), whereas the increase in cortisol secretion in hypothyroid patients is only 20% greater than that of control at peak level (Fig. 1B), indicating that adrenocortical response to ACTH is decreased by hypothyroidism. Furthermore, although cortisol levels in hypo- and hyperthyroid patients are similar (Fig. 2B), adrenal secretion of cortisol may be greater in hyperthyroid patient, since UFC secretion is significantly increased in hyperthyroid patient (Table 1), which may reduce plasma cortisol levels. Thus, although both hyper- and hypothyroidism induced hypersecretion of ACTH to hcrh, and cortisol levels were also significantly greater compared with those of normal subject, hormonal status within HPA axis may be different between hyper- and hypothyroid conditions. In conclusion, both hyper- and hypothyroidism may induce hypersecretion of ACTH in response to hcrh treatment. Adrenocortical hormonal status is differentially altered under these conditions. Currently, the major concern on the side effect of thyroid suppression therapy has been confined within cardiovascular system and bone mineral density. However, disruption of HPA axis by altered thyroid hormone status by thyroid suppression therapy may induce abnormal stress response, which may lead to depressive or cognitive disorders. References 1. Samuels MH, Schuff KG, Carlson NE, Carello JS, Janowsky JS (2007) Health status, mood, and cognition in experimentally induced subclinical hypothyroidism. J Clin Endocrinol Metab 92: Williams M, Harris R, Dayan C, Evans J, Gallacher J, Ben-Shlomo Y (2009) Thyroid function and the natural history of depression: findings from the Caerphilly Prospective Study (CaPS) and a meta-analysis. Clin Endocrinol (Oxf) 70: Sgarbi JA, Matsumura LK, Kasamatsu TS, Ferreira SR, Maciel R (2010) Subclinical thyroid dysfunctions are indepednet risk factors for mortality in a 7.5 year follow-up: the Japanese-Brazilian thyroid study. Eur J Endocrinol 162: Wilson S, Parle JV, Roberts LM, Roalfe FD, Hobbs R, Clark P, Sheppard MC, Gammage MD, Pattison HM, Franklyn JA On behalf of the Birmingham Elderly Thyroid study Team (2006) Prevalence of subclinical thyroid dysfunction and its relation to socioeconomic deprivation in the elderly: a community-based crosssectional survey. J Clin Endocrinol Metab 91: Samuels MH (2008) Cognitive function in untreated hypothyroidism and hyperthyroidism. Curr Opin Endocrinol Diabetes Obes 15: Lizcano F, Salvador J (2008) Effects of different treatments for hyperthyroidism on the hypothalamic - pituitary - adrenal axis. Clin Exp Phar Phys 35: Tsatsoulis A, Johnson EO, Kalogera CH, Seferiadis K, Tsolas O (2000) The effect of thyrotoxicosis on adrenocortical reserves. Eur J Endocrinol 142: Biondi B, Cooper DS (2008) The clinical significance of subclinical thyroid dysfunction. Endocr Rev 29: Roberts LM, Pattison H, Roalfe A, Franklyn J, Wilson S, Hobbs FD, Parle JV (2006) Is subclinical thyroid dysfunction in the elderly associated with depression or
6 142 Lizcano et al. cognitive dysfunction? Ann Intern Med 145: Horroks PM, Jones AF, Ratcliffe WA, Holder A, White R, Holder JG, Ratcliffe DR, London DR (1990) Patterns of ACTH and cortisol pulsatility over twenty-four hours in normal males and females. Clin Endo 32: Kamilaris TC, DeBold CR, Johnson EO, Mamalaki E, Listwak SJ, Calogero AE, Kalogeras KT, Gold PW, Orth DN (1991) Effects of short and long duration hypothyroidism and hyperthyroidism on the plasma adrenocorticotropin and corticosterone responses to ovine corticotropin-releasing hormone in rats. Endocrinology 128: Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferry SL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM (2009) Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 19: Johnson EO, Kamilaris TC, Calogero AE, Gold PW, Chrousos GP (2005) Experimental induced hyperthyroidism is associated with activation of the rat hypothalamic-pituitary-adrenal axis. Eur J Endo 153: Tohei A, Akai M, Tomabechi T, Mamada M, Taya K (1997) Adrenal and gonadal function in hypothyroid adult male rats. J Endocr 152:
The effect of thyrotoxicosis on adrenocortical reserve
European Journal of Endocrinology (2000) 142 231 235 ISSN 0804-4643 CLINICAL STUDY The effect of thyrotoxicosis on adrenocortical reserve A Tsatsoulis, E O Johnson, C H Kalogera 1, K Seferiadis 1 and O
More informationSupplementary Online Material
Supplementary Online Material Collet T-H, Gussekloo J, Bauer DC, et al; Thyroid Studies Collaboration. Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Arch Intern Med.
More informationChapter I.A.1: Thyroid Evaluation Laboratory Testing
Chapter I.A.1: Thyroid Evaluation Laboratory Testing Jennifer L. Poehls, MD and Rebecca S. Sippel, MD, FACS THYROID FUNCTION TESTS Overview Thyroid-stimulating hormone (TSH) is produced by the anterior
More informationRADIOIMMUNOASSAY OF THYROID RELATED HORMONES AND TSH IN PRIMARY HYPERTHYROIDISM
RADIOIMMUNOASSAY OF THYROID RELATED HORMONES AND TSH IN PRIMARY HYPERTHYROIDISM Pages with reference to book, From 215 To 219 Farida Agha ( Pakistan Medical Research Council, Research Centre, Karachi.
More informationCHISCG1: Short Synacthen Test for the Investigation of Adrenal Insufficiency
Pathology at the Royal Derby Hospital Short Synacthen Test Standard Clinical Guidelines Chemical Pathology Department Valid Until 31 st August 2011 Document Code: CHISCG1 Short Synacthen Test for the Investigation
More informationChecking the Right Box at the Right Age: the Art of Pediatric Endocrine Testing
Checking the Right Box at the Right Age: the Art of Pediatric Endocrine Testing Jean-Pierre Chanoine, MD Endocrinology and Diabetes Unit British Columbia s Children s Hospital Objectives 1. Interpret the
More informationAlthough adequate treatment of differentiated thyroid
Serum Thyroglobulin Concentrations and 131 I Whole-Body Scan Results in Patients with Differentiated Thyroid Carcinoma After Administration of Recombinant Human Thyroid-Stimulating Hormone Alessia David,
More informationEndocrine part one. Presented by Dr. Mohammad Saadeh The requirements for the Clinical Chemistry Philadelphia University Faculty of pharmacy
Endocrine part one Presented by Dr. Mohammad Saadeh The requirements for the Clinical Chemistry Philadelphia University Faculty of pharmacy HORMONES Hormones are chemicals released by a cell or a gland
More informationTHE DEVELOPMENT of highly sensitive and precise
0021-972X/97/$03.00/0 Vol. 82, No. 3 Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright 1997 by The Endocrine Society Estimation of Tissue Hypothyroidism by a New Clinical Score:
More informationULTIMATE BEAUTY OF BIOCHEMISTRY. Dr. Veena Bhaskar S Gowda Dept of Biochemistry 30 th Nov 2017
ULTIMATE BEAUTY OF BIOCHEMISTRY Dr. Veena Bhaskar S Gowda Dept of Biochemistry 30 th Nov 2017 SUSPECTED CASE OF CUSHING S SYNDROME Clinical features Moon face Obesity Hypertension Hunch back Abdominal
More informationAnalysis of Lag Behind Thyrotropin State After Radioiodine Therapy in Hyperthyroid Patients
Analysis of Lag Behind Thyrotropin State After Radioiodine Therapy in Hyperthyroid Patients ORIGINAL ARTICLE Mohshi Um Mokaddema, Fatima Begum, Simoon Salekin, Tanzina Naushin, Sharmin Quddus, Nabeel Fahmi
More informationLimited Diagnostic Utility of Plasma Adrenocorticotropic Hormone for Differentiation between Adrenal Cushing Syndrome and Cushing Disease
Original Article Endocrinol Metab 215;3:297-34 http://dx.doi.org/1.383/enm.215.3.3.297 pissn 293-596X eissn 293-5978 Limited Diagnostic Utility of Plasma Adrenocorticotropic Hormone for Differentiation
More informationSanjay B. Dixit, M.D. BHS Endocrinology Associates November 11, 2017
Sanjay B. Dixit, M.D. BHS Endocrinology Associates November 11, 2017 I will not be discussing this Outline of discussion Laboratory tests for thyroid function Diagnosis of hypothyroidism Treatment of
More informationEvaluation and Management of Pituitary Failure. Dr S. Ali Imran MBBS, FRCP (Edin), FRCPC Professor of Medicine Dalhousie University, Halifax, NS
Evaluation and Management of Pituitary Failure Dr S. Ali Imran MBBS, FRCP (Edin), FRCPC Professor of Medicine Dalhousie University, Halifax, NS Conflict of Interest None Objectives Diagnostic approach
More informationProspective Observation of 5-Year Clinical Course of Subclinical Hypothyroidism in Korean Population
ORIGINAL ARTICLE Endocrinology, Nutrition & Metabolism http://dx.doi.org/10.3346/jkms.2013.28.11.1622 J Korean Med Sci 2013; 28: 1622-1626 Prospective Observation of 5-Year Clinical Course of Subclinical
More informationThyroid Cancer & rhtsh: When and How?
Thyroid Cancer & rhtsh: When and How? 8 th Postgraduate Course in Endocrine Surgery Capsis Beach, Crete, September 21, 2006 Quan-Yang Duh, Professor of Surgery, UCSF Increasing Incidence of Thyroid Cancer
More informationTOP 20 - THYROID ARTICLES
TOP 20 - THYROID ARTICLES The following is a list of twenty outstanding articles which have occurred in the thyroid literature during the past few years. These articles have been selected by Jerome M.
More informationTHYROID HORMONES & THYROID FUNCTION TESTS
THYROID HORMONES & THYROID FUNCTION TESTS SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES DISCIPLINE OF BIOCHEMISTRY AND MOLECULAR BIOLOGY CLINICAL BIOCHEMISTRY LECTURE BMLS III
More informationEndocrine part two. Presented by Dr. Mohammad Saadeh The requirements for the Clinical Chemistry Philadelphia University Faculty of pharmacy
Endocrine part two Presented by Dr. Mohammad Saadeh The requirements for the Clinical Chemistry Philadelphia University Faculty of pharmacy Cushing's disease: increased secretion of adrenocorticotropic
More informationCritical illness and endocrinology. ICU Fellowship Training Radboudumc
Critical illness and endocrinology ICU Fellowship Training Radboudumc Critical illness Ultimate form of severe physical stress Generates an orchestrated endocrine response to provide the energy for fight
More informationTHYROID HORMONES: An Overview
1 SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES DISCIPLINE OF BIOCHEMISTRY AND MOLECULAR BIOLOGY PBL SEMINAR MBBS III; BMLS & BDS Year 3 What are the Thyroid Hormones? THYROID
More informationAudit of Adrenal Function Tests. Kate Davies Senior Lecturer in Children s Nursing London South Bank University London, UK
Audit of Adrenal Function Tests Kate Davies Senior Lecturer in Children s Nursing London South Bank University London, UK Introduction Audit Overview of adrenal function tests Education Audit why? Explore
More informationNone. Thyroid Potpourri for the Primary Care Physician. Evaluating Thyroid Function. Disclosures. Learning Objectives
Thyroid Potpourri for the Primary Care Physician Ramya Vedula DO, MPH, ECNU Endocrinology, Diabetes and Metabolism Princeton Medical Group Assistant Professor of Clinical Medicine Rutgers Robert Wood Johnson
More informationRequesting and Management of abnormal TFTs.
Requesting and Management of abnormal TFTs. At the request of a number of GPs I have produced summary guidelines surrounding thyroid testing. These have been agreed with our Endocrinology leads Dr Bell
More informationC h a p t e r 3 8 Cushing s Syndrome : Current Concepts in Diagnosis and Management
C h a p t e r 3 8 Cushing s Syndrome : Current Concepts in Diagnosis and Management Padma S Menon Professor of Endocrinology, Seth G S Medical College & KEM Hospital, Mumbai A clinical syndrome resulting
More informationWhat Current Research Says About Measuring Cortisol and the HPA axis
What Current Research Says About Measuring Cortisol and the HPA axis Recent research provides a clearer link between stress and its impact on health. Whether that stress is acute or chronic, it can affect
More informationLiving Control Mechanisms
Living Control Mechanisms Dr Kate Earp MBChB MRCP Specialty Registrar Chemical Pathology & Metabolic Medicine kate.earp@sth.nhs.uk 15/10/2015 Contents Aims & objectives Homeostasis Cell communication Introduction
More informationThe subjects were participants in a Dutch national prospective study, running from April
Supplemental Data Subjects The subjects were participants in a Dutch national prospective study, running from April 1, 1994 to April 1, 1996. Infants with neonatal screening results indicative of CH-C
More informationCortisol (serum, plasma)
Cortisol (serum, plasma) 1 Name and description of analyte 1.1 Name of analyte Cortisol 1.2 Alternative names Hydrocortisone, 11β; 17, 21 trihydroxypregn 4 ene 3,20 dione 1.3 NMLC code 1.4 Description
More informationThyroid Function TSH Analyte Information
Thyroid Function TSH Analyte Information 1 2013-05-01 Thyroid-stimulating hormone (TSH) Introduction Thyroid-stimulating hormone (thyrotropin, TSH) is a glycoprotein with molecular weight of approximately
More informationThyroid in the elderly. Akbar Soltani M.D. Endocrinology and Metabolism Research Center (EMRC) Shariati Hospital
Thyroid in the elderly Akbar Soltani M.D. Endocrinology and Metabolism Research Center (EMRC) Shariati Hospital soltania@tuma.ac.ir Case 1 A 79 year old female is seen because of a 6 month history of fatigue,
More informationXiaoli Liu 1, Ying Zhou 1, Nan Liang 1, Yang Hong 1, Gianlorenzo Dionigi 2, Hui Sun 1. Original Article
Original Article The effect of long-term thyroid-stimulating hormone suppressive therapy on the gonadal steroid hormones of patients with thyroid carcinoma after surgery Xiaoli Liu 1, Ying Zhou 1, Nan
More informationThyroid disorders. Dr Enas Abusalim
Thyroid disorders Dr Enas Abusalim Thyroid physiology The hypothalamic pituitary thyroid axis And peripheral conversion of T4 to T3, WHERE, AND BY WHAT ENZYME?? Only relatively small concentrations of
More informationB-Resistance to the action of hormones, Hormone resistance characterized by receptor mediated, postreceptor.
Disorders of the endocrine system 38 Disorders of endocrine system mainly are caused by: A-Deficiency or an excess of a single hormone or several hormones: - deficiency :can be congenital or acquired.
More informationUpdate on Gestational Thyroid Disease. Aidan McElduff The Discipline of Medicine, The University of Sydney
IADPSG 2016 Update on Gestational Thyroid Disease Aidan McElduff The Discipline of Medicine, The University of Sydney IADPSG 2016 DISCLOSURES and AIM Nil to disclose Aim: to provide an overview 2017 Guidelines
More informationMelatonin and Growth Hormone Deficiency: A Contribution to the Evaluation of Neuroendocrine Disorders
Melatonin and Growth Hormone Deficiency: A Contribution to the Evaluation of Neuroendocrine Disorders Fideleff G., Suárez M., Boquete HR, Azaretzky M., Sobrado P., Brunetto O*, Fideleff HL Endocrinology
More informationENDOCRINOLOGY COORDINATION OF PHYSIOLOGICAL PROCESSES:
ENDOCRINOLOGY COORDINATION OF PHYSIOLOGICAL PROCESSES: -In a living organism there must be coordination of number of physiological activities taking place simultaneously such as: movement, respiration,
More informationPrognosis of thyroid function after hemithyroidectomy
Cent. Eur. J. Med. 6(2) 2011 152-157 DOI: 10.2478/s11536-010-0064-z Central European Journal of Medicine Prognosis of thyroid function after hemithyroidectomy Research Article V. Beiša, D. Kazanavičius
More informationUnderstanding thyroid function tests. Dr. Colette George
Understanding thyroid function tests Dr. Colette George Disclosures No financial disclosure I will present fictitious cases and thyroid function tests (TFTs) that are based on scenarios I commonly encounter.
More informationTHERAPEUTIC DOSES OF radioactive iodine ( 131 I; RAI)
0021-972X/04/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 89(7):3285 3289 Printed in U.S.A. Copyright 2004 by The Endocrine Society doi: 10.1210/jc.2003-031139 Rapid Rise in Serum Thyrotropin
More informationThyroid Nodules. Dr. HAKIMI, SpAK Dr. MELDA DELIANA, SpAK Dr. SISKA MAYASARI LUBIS, SpA
Thyroid Nodules ENDOCRINOLOGY DIVISION ENDOCRINOLOGY DIVISION Dr. HAKIMI, SpAK Dr. MELDA DELIANA, SpAK Dr. SISKA MAYASARI LUBIS, SpA Anatomical Considerations The Thyroid Nodule Congenital anomalies Thyroglossal
More informationPage 1. Understanding Common Thyroid Disorders. Cases. Topics Covered
Cases Understanding Common Thyroid Disorders Douglas C. Bauer, MD UCSF Division of General Internal Medicine No Disclosures 66 yr old female with 1 yr of fatigue and lassitude and no findings except TSH=8.2,
More informationThe Thyroid Axis Setpoints are Significantly Altered After Long-Term Suppressive LT4 Therapy
79 Endocrine Care The Thyroid Axis Setpoints are Significantly Altered After Long-Term Suppressive LT Therapy Authors F. A. Verburg 1,, U. Mäder 3, I. Grelle 1, T. J. Visser, R. P. Peeters, J. W. A. Smit
More informationmight be due to a direct action on the thyroid, like that of the thiouracil
288 J. Physiol. (1953) I20, 288-297 COMPARISON OF THE EFFECTS OF THIOURACIL, THY- ROXINE AND CORTISONE ON THE THYROID FUNCTION OF RABBITS BY N. B. MYANT* From the Department of Clinical Research, University
More informationNatural History and Comorbidities of Subjects with Subclinical Hyperthyroidism: Analysis at a Tertiary Hospital Setting
506 Original Article Natural History and Comorbidities of Subjects with Subclinical Hyperthyroidism: Analysis at a Tertiary Hospital Setting Shaikh Abdul Kader Kamaldeen Abdul Shakoor, 1 MBBS, MD, MRCP
More informationDOWNLOAD OR READ : SYNDROME OF INAPPROPRIATE SECRETION OF ANTIDIURETIC HORMONE IN MALIGNANCY PDF EBOOK EPUB MOBI
DOWNLOAD OR READ : SYNDROME OF INAPPROPRIATE SECRETION OF ANTIDIURETIC HORMONE IN MALIGNANCY PDF EBOOK EPUB MOBI Page 1 Page 2 syndrome of inappropriate secretion of antidiuretic hormone in malignancy
More informationTrust Guideline for the Management of: Abnormal Pre-operative Thyroid Function Tests in Adults. Anaesthetists Abnormal Pre-op Thyroid Function Test
For Use in: By: For: Pre-operative Thyroid Function Tests in Adults Division responsible for document: Key words: Name and job titles of document author: Name and job title of document author s Line Manager:
More informationProgram Outline / page 1. I. Get Acquainted With Your Hormone System. III. Learn Why The Thyroid Gland is Important for Your Health
Program Outline / page 1 Module 1 I. Get Acquainted With Your Hormone System What is the endocrine system? What are hormonal rhythms? What are the main hormonal networks and axis? II. Know Your Thyroid
More informationAre Bioequivalence Studies of Levothyroxine Sodium Formulations in Euthyroid Volunteers Reliable?
THYROID Volume 14, Number 3, 2004 Mary Ann Liebert, Inc. Are Bioequivalence Studies of Levothyroxine Sodium Formulations in Euthyroid Volunteers Reliable? Vicky Blakesley, 1 Walid Awni, 1 Charles Locke,
More informationDecoding Your Thyroid Tests and Results
Decoding Your Thyroid Tests and Results Wondering about your thyroid test results? Learn about each test and what low, optimal, and high results may mean so you can work with your doctor to choose appropriate
More informationTOTAL OR NEAR-TOTAL thyroidectomy is advocated in
0013-7227/03/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 88(3):1107 1111 Printed in U.S.A. Copyright 2003 by The Endocrine Society doi: 10.1210/jc.2002-021365 Positive Predictive Value
More informationIs the plasma ACTH concentration a reliable parameter in the insulin tolerance test?
European Journal of Endocrinology (2003) 149 535 541 ISSN 0804-4643 CLINICAL STUDY Is the plasma ACTH concentration a reliable parameter in the insulin tolerance test? K Borm, M Slawik, L Seiler, F Flohr,
More informationSlide notes: This presentation provides information on Graves disease, a systemic autoimmune disease. Epidemiology, pathology, complications,
1 This presentation provides information on Graves disease, a systemic autoimmune disease. Epidemiology, pathology, complications, including ophthalmic complications, treatments (both permanent solutions
More informationJim Paoletti BS Pharmacy, FAARM, FIACP, Director of Education, P2P
presents A Pioneering Functional Technologies Approach For to Hypothyroidism Lifestyle Based Medicine Part 3 of 3 with Jim Paoletti BS Pharmacy, FAARM, FIACP, Director of Education, P2P Clinical Consultant
More informationLABORATORY TESTS FOR EVALUATION OF THYROID DISORDERS
LABORATORY TESTS FOR EVALUATION OF THYROID DISORDERS Maryam Tohidi Anatomical & clinical pathologist Research Institute for Endocrine Sciences THYROID GLAND (15-25 gr), (12-20 gr), 2 lobes connected by
More informationTHE AIM OF postsurgical follow-up in patients with differentiated
0013-7227/01/$03.00/0 The Journal of Clinical Endocrinology & Metabolism 86(12):5686 5690 Printed in U.S.A. Copyright 2001 by The Endocrine Society Prediction of Disease Status by Recombinant Human TSH-Stimulated
More informationRecords after duplicates removed (n = 2274) Records screened (n = 2274) Full-text articles assessed for eligibility (n = 16)
Supplemental Figure 1 Adapted from Prisma Flow Chart Records identified through database searching (n = 3093) Additional records identified through other sources (n = 2) Records after duplicates removed
More informationMastering Thyroid Disorders. Douglas C. Bauer, MD UCSF Division of General Internal Medicine
Mastering Thyroid Disorders Douglas C. Bauer, MD UCSF Division of General Internal Medicine Cases 68 yr old female with new atrial fibrillation and no other findings except TSH=0.04, normal free T4 79
More informationCommon Issues in Management of Hypothyroidism
Common Issues in Management of Hypothyroidism Family Medicine Refresher Course April 5, 2018 Janet A. Schlechte, M.D. Disclosure of Financial Relationships Janet A. Schlechte, M.D. has no relationships
More informationLothian Guidance for Diagnosis and Management of Thyroid Dysfunction in Pregnancy
Lothian Guidance for Diagnosis and Management of Thyroid Dysfunction in Pregnancy Early diagnosis and good management of maternal thyroid dysfunction are essential to ensure minimal adverse effects on
More informationEndocrinological Outcome Among Treated Craniopharyngioma Patients
Endocrinological Outcome Among Treated Craniopharyngioma Patients Afaf Al Sagheir, MD Head & Consultant, Section of Endocrinology/Diabetes Department of Pediatrics KFSH&RC Introduction Craniopharyngiomas
More informationPITUITARY: JUST THE BASICS PART 2 THE PATIENT
PITUITARY: JUST THE BASICS PART 2 THE PATIENT DISCLOSURE Relevant relationships with commercial entities none Potential for conflicts of interest within this presentation none Steps taken to review and
More informationI-131 ABLATION AND ADJUVANT THERAPY OF THYROID CANCER
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS Advances in Medical and Surgical Management of Thyroid Cancer January 23-24, 2015 I-131 ABLATION AND ADJUVANT THERAPY OF THYROID CANCER 2015 Leonard Wartofsky,
More informationAhmed Al Nahari Pediatric Endocrinology Fellow March 11,2016
Ahmed Al Nahari Pediatric Endocrinology Fellow March 11,2016 Scholar: Review the literature in an evidenced based manner to determine the difference in our clinical setting. Advocate: Develop a better
More informationKovilvenni, Thiruvarur Dist.,Tamilnadu, India. ABSTRACT:
A Mathematical Reliability Growth Model using for Acute HPA Axis Responses, Heart Rate and Mood Changes to Psychosocial Stress in Human at Different s of Day S. Lakshmi * and A. Manickam ** * Principal
More informationThyroid stimulating hormone suppression time on cardiac function of patients with differentiated thyroid carcinoma
https://doi.org/10.1186/s12935-018-0686-9 Cancer Cell International PRIMARY RESEARCH Open Access Thyroid stimulating hormone suppression time on cardiac function of patients with differentiated thyroid
More informationCED-SOS Advice Report 5 EDUCATION AND INFORMATION 2012
CED-SOS Advice Report 5 EDUCATION AND INFORMATION 2012 Recombinant Humanized Thyroid Stimulating Hormone () Preparation Prior To Radioiodine Ablation in Patients Who Have Undergone Thyroidectomy for Papillary
More informationThyroid Management. Evolving Controversy - Science, Dogma, Opinion. The Ogden Surgical Medical Society May 2016
Thyroid Management Evolving Controversy - Science, Dogma, Opinion The Ogden Surgical Medical Society May 2016 Published Guidelines AACE and ATA - Clinical Practice Guidelines in 2012 Guidelines are neither
More informationHormonal disturbances associated with obesity in dogs
DOI: 10.1111/j.1439-0396.2005.00589.x ORIGINAL ARTICLE Hormonal disturbances associated with obesity in dogs L. J. M. Martin, B. Siliart, H. J. W. Dumon and P. G. Nguyen Unité de Nutrition et Endocrinologie,
More informationSample Type - Serum Result Reference Range Units. Central Thyroid Regulation Surrey & Activity KT3 4Q. Peripheral Thyroid D Function mark
Thyroid Plus Sample Type - Serum Result Reference Range Units Central Thyroid Regulation Surrey & Activity KT3 4Q Total Thyroxine (T4)
More informationCushings Syndrome. Cushings Syndrome
We have made it easy for you to find a PDF Ebooks without any digging. And by having access to our ebooks online or by storing it on your computer, you have convenient answers with cushings syndrome. To
More informationThyroid profile in geriatric population
Original article: Thyroid profile in geriatric population Dr. Abhijit Pratap, Dr. Mona A. Tilak, Dr. Pradnya Phalak Dept of Biochemistry, Dr. D. Y. Patil Medical College, Pimpri, Pune 18 Corresponding
More informationThyroid Update. Timothy C. Petersen, MD, ECNU
Thyroid Update Timothy C. Petersen, MD, ECNU TPMG Coastal Endocrinology Virginia Beach, VA About Me Board Certified Endocrinology, Diabetes, and Metabolism Internal Medicine ECNU Certified Endocrine Certification
More informationEvaluation of growth hormone-releasing peptide-2 for diagnosis of thyrotropin-producing pituitary adenomas
NOTE doi:10.1507/endocrj.ej17-0527 Evaluation of growth hormone-releasing peptide-2 for diagnosis of thyrotropin-producing pituitary adenomas Kazunori Kageyama 1), Satoru Sakihara 1) *, Wataru Kameda 2),
More informationPituitary Tumors and Incidentalomas. Bijan Ahrari, MD, FACE, ECNU Palm Medical Group
Pituitary Tumors and Incidentalomas Bijan Ahrari, MD, FACE, ECNU Palm Medical Group Background Pituitary incidentaloma: a previously unsuspected pituitary lesion that is discovered on an imaging study
More informationQuality of Life in Cured patients with Differentiated Thyroid Carcinoma
11 Quality of Life in Cured patients with Differentiated Thyroid Carcinoma Karen A. Heemstra, Hendrieke C. Hoftijzer, Eleonora P.M. Corssmit, Agatha A. van der Klaauw, Johannes A. Romijn, Johannes W.A.
More informationEpidemiological Study of T4, T3 and TSH Mean Concentrations in Four Iranian Populations
Iranian J Publ Health, 2005, Vol. 34, No. Iranian 1, pp.74-79 J Publ Health, 2005, Vol. 34, No. 1, pp.74-79 Epidemiological Study of T4, T3 and TSH Mean Concentrations in Four Iranian Populations *M Fathzadeh
More informationPhysiology Of The Hypothalamic Pituitary Thyroid Axis
Physiology Of The Hypothalamic Pituitary Thyroid Axis 1 / 6 2 / 6 3 / 6 Physiology Of The Hypothalamic Pituitary INTRODUCTION. The hypothalamus can be considered the coordinating center of the endocrine
More informationHYPERTHYROIDISM. Hypothalamus. Thyrotropin-releasing hormone (TRH) Anterior pituitary gland. Thyroid-stimulating hormone (TSH) Thyroid gland T4, T3
HYPERTHYROIDISM Hypothalamus Thyrotropin-releasing hormone (TRH) Anterior pituitary gland Thyroid-stimulating hormone (TSH) Thyroid gland T4, T3 In hyperthyroidism, there is an increased production of
More informationALPRAZOLAM (ALP), a benzodiazepine that activates
0021-972X/99/$03.00/0 Vol. 84, No. 8 The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright 1999 by The Endocrine Society The Inhibitory Effect of Alprazolam, a Benzodiazepine,
More informationTable 1: Thyroid panel. Result (reference interval) TSH 89.5 miu/l ( ) Total T4 5.2 µg/dl ( ) T3 uptake 39% (22-35)
Introduction Thyroid disease is the second most common endocrine disorder (behind diabetes), and its prevalence increases with increasing age. The incidence of newly diagnosed thyroid cancer is increasing
More informationSome Issues in the Management of Hypothyroidism
Some Issues in the Management of Hypothyroidism Family Medicine Refresher Course April 6, 2016 Janet A. Schlechte, M.D. Disclosure of Financial Relationships Janet A. Schlechte, M.D. has no relationships
More informationThyrotoxicosis in Pregnancy: Diagnose and Management
Thyrotoxicosis in Pregnancy: Diagnose and Management Yuanita Asri Langi email: meralday@yahoo.co.id Endocrinology & Metabolic Division, Internal Medicine Department, Prof.dr.R.D. Kandou Hospital/ Sam Ratulangi
More informationThyroid Plus. Central Thyroid Regulation & Activity. Peripheral Thyroid Function. Thyroid Auto Immunity. Key Guide. Patient: DOB: Sex: F MRN:
Thyroid Plus Patient: DOB: Sex: F MRN: Order Number: Completed: Received: Collected: Sample Type - Serum Result Reference Range Units Central Thyroid Regulation & Activity Total Thyroxine (T4) 127 127
More informationThe interpretation and management of thyroid disorders
Journal of Endocrinology, Metabolism and Diabetes of South Africa 2015 ; 20(2) http://dx.doi.org/10.1080/16089677.2015.1056468 Open Access article distributed under the terms of the Creative Commons License
More informationPhysiological processes controlled by hormones?
: the study of hormones, their receptors, the intracellular signaling pathways they invoke, and the diseases and conditions associated with them. What are hormones? Major endocrine glands? Fig 7-2 Physiological
More informationEndocrine Emergencies: Recognition and Management
Endocrine Emergencies: Recognition and Management John Wass Department of Endocrinology, Oxford University, UK An Update on Acute Medical Emergencies for Psychiatrists Royal College of Psychiatrists' address
More informationPDF hosted at the Radboud Repository of the Radboud University Nijmegen
PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is a publisher's version. For additional information about this publication click this link. http://hdl.handle.net/2066/16752
More informationLothian Guidance for Diagnosis and Management of Thyroid Dysfunction in Pregnancy.
Lothian Guidance for Diagnosis and Management of Thyroid Dysfunction in Pregnancy. Early diagnosis and good management of maternal thyroid dysfunction is essential to ensure minimal adverse effects on
More informationMidnight salivary cortisol, measured by highly sensitive electrochemiluminescence immunoassay, for the diagnosis of Cushing s syndrome
Cent. Eur. J. Med. 4(1) 2009 59-64 DOI: 10.2478/s11536-009-0004-y Central European Journal of Medicine Midnight salivary cortisol, measured by highly sensitive electrochemiluminescence immunoassay, Maria
More informationThe endocrine system is made up of a complex group of glands that secrete hormones.
1 10. Endocrinology I MEDCHEM 535 Diagnostic Medicinal Chemistry Endocrinology The endocrine system is made up of a complex group of glands that secrete hormones. These hormones control reproduction, metabolism,
More informationCase Report. Michael H. Goldman, MD; Alison T. Gruber; Marc A. Herman, MD ABSTRACT
Case Report CONCURRENT PANHYPOPITUITARISM AND HYPERPROLACTINEMIA DUE TO A GIANT INTERNAL CAROTID ANEURYSM REVEALED BY THYROID HORMONE WITHDRAWAL DURING FOLLOW-UP MANAGEMENT OF THYROID CANCER Michael H.
More informationLecture title. Name Family name Country
Lecture title Name Family name Country Nguyen Thy Khue, MD, PhD Department of Endocrinology HCMC University of Medicine and Pharmacy, MEDIC Clinic Hochiminh City, Viet Nam Provided no information regarding
More informationHypothalamus & Pituitary Gland
Hypothalamus & Pituitary Gland Hypothalamus and Pituitary Gland The hypothalamus and pituitary gland form a unit that exerts control over the function of several endocrine glands (thyroid, adrenals, and
More informationCover Page. The handle holds various files of this Leiden University dissertation.
Cover Page The handle http://hdl.handle.net/1887/36317 holds various files of this Leiden University dissertation. Author: Abdulrahman Hareedy, Randa Mostafa Title: Clinical and molecular studies on differentiated
More informationBack to the Basics: Thyroid Gland Structure, Function and Pathology
Back to the Basics: Thyroid Gland Structure, Function and Pathology JANELLE M. CHIASERA LEARNING OBJECTIVES 1. Explain the HPT feedback system involving the thyroid gland. Include the hormone produced
More informationResistance to Thyroid Hormone and Down Syndrome: Coincidental Association or. Genetic Linkage?
Page 1 of 6 1 Resistance to Hormone and Down Syndrome: Coincidental Association or Genetic Linkage? (doi: 10.1089/thy.2011-0316) Resistance to Hormone and Down Syndrome: Coincidental Association or Genetic
More informationX/97/$03.00/0 Vol. 82, No. 6 Journal of Clinical Endocrinology and Metabolism Copyright 1997 by The Endocrine Society
0021-972X/97/$03.00/0 Vol. 82, No. 6 Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright 1997 by The Endocrine Society Effectiveness Versus Efficacy: The Limited Value in Clinical
More informationRhythm Plus- Comprehensive Female Hormone Profile
Rhythm Plus- Comprehensive Female Hormone Profile Patient: SAMPLE REPORT DOB: Sex: F Order Number: K00000 Completed: Received: Collected: SAMPLE REPORT Sample # Progesterone (pg/ml) Hormone Results Oestradiol
More informationThe analysis of Glucocorticoid Steroids in Plasma, Urine and Saliva by UPLC/MS/MS
The analysis of Glucocorticoid Steroids in Plasma, Urine and Saliva by UPLC/MS/MS Brett McWhinney, Supervising Scientist, HPLC Section, Pathology Central, Pathology Queensland Overview 1. Overview of Pathology
More information